C

CellOrigin Biotech

5 employees

CellOrigin Biotech is a company committed to iPSC-derived innate immune cell therapeutics.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Date founded

2018

Funding rounds raised

Total raised

$16M

from 4 investors over 4 rounds

C

CellOrigin Biotech raised $16M on March 29, 2022

Investors: Efung Capital, Kunlun Capital Pte. Ltd. and Jifeng Ventures 济峰资本

C

CellOrigin Biotech raised undisclosed on July 20, 2021

Investors: Beijing Kunlun Tech Co Ltd (SZ:300418)

FAQ